Latest news with #HIVTesting
CNN
2 days ago
- Health
- CNN
Inside the CDC, shooting adds to trauma as workers describe projects, careers in limbo
Federal agencies Gun violence Donald TrumpFacebookTweetLink Follow Centers for Disease Control and Prevention workers whose jobs have been reinstated after dizzying Trump administration disruptions say they remain stuck in a budgetary, political, and professional limbo. Their work includes major agency priorities such as HIV testing and monitoring, as well as work at the nation's leading sexually transmitted infections lab. And while employees are back, many projects have been canceled or stalled, as funding disappears or is delayed. 'For a while, work was staring at a blank screen,' an HIV scientist said. 'I had a couple of projects before this. I'm trying to get them restarted.' 'We don't know what's happening or what to do,' said an HIV prevention researcher who was fired then rehired. These employees voiced deep concern over the future of the agency and its work on HIV and other threats. The unprecedented downsizing could lead to loss of life and higher spending on medical care, they say. Their uncertain employment status has sunk morale. Many worry about the future of public health. On Aug. 8, a gunman identified by Georgia authorities as Patrick Joseph White fired shots at CDC buildings in Atlanta. A first responder on the scene, DeKalb County police officer David Rose, was killed. White, who was found dead, was possibly motivated by his views on vaccines, according to news reports. The attack added another level of anxiety for agency workers. 'We feel threatened from inside, and, obviously, now from outside,' a lab scientist said Aug. 10. 'The trauma runs so differently in all of us. And is this the last straw for some of us? The overall morale — would you go back in the building and you could be shot at?' Healthbeat interviewed 11 CDC workers, who offered a rare glimpse into conditions at the agency. All but one had been fired then offered their jobs back. Most have worked on HIV-related projects for at least several years. All spoke on the condition of anonymity, citing a fear of retaliation. They fear their employment, in the HIV scientist's terms, 'is on shaky ground.' 'I'm concerned there is chaos and that we lost ground on HIV prevention' from reductions in data collection and layoffs of local public health workers, an HIV epidemiologist said. 'I feel like a pawn on a chessboard.' HHS spokesperson Emily Hilliard responded to a query with this statement: 'Under Secretary Kennedy's leadership, the nation's critical public health functions remain intact and effective. The Trump administration is committed to protecting essential services — whether it's supporting coal miners and firefighters through NIOSH, safeguarding public health through lead prevention, or researching and tracking the most prevalent communicable diseases. HHS is streamlining operations without compromising mission-critical work. Enhancing the health and well-being of all Americans remains our top priority.' The workers received some positive news July 31, when a Senate committee voted to keep CDC funding at more than $9 billion, near its current level. 'It is very encouraging, but that's only one step in the appropriations process,' the HIV researcher said. Still, under the Trump administration's budget request, the CDC's programs on HIV face uncertainty. John Brooks, who retired as chief medical officer of the CDC's Division of HIV Prevention last year, expressed concern over the Ending the HIV Epidemic initiative. Launched in President Donald Trump's first term, it 'breathed new life into HIV prevention,' Brooks said. The successes of the Ending the HIV Epidemic initiative are jeopardized by the administration plan to scale back HIV prevention efforts, Brooks said. That would include the potential elimination of the CDC Division of HIV Prevention, which provides funds to state health departments and other groups for testing and prevention, conducts HIV monitoring and surveillance, researches HIV prevention and care, and assists medical professionals with training and education. 'There is no way to achieve the goals of EHE without maintaining the national prevention infrastructure it depends on,' Brooks said. 'There is every reason to worry that in fact new HIV infections will rise again.' Under Secretary Robert F. Kennedy Jr., the Department of Health and Human Services carried out widespread layoffs at the CDC and other health agencies beginning in early April. Lawsuits over those mass firings are playing out in federal courts. The administration's budget blueprint would move CDC HIV work — with many fewer employees, according to people Healthbeat interviewed — to the Administration for a Healthy America, a new HHS division Kennedy has championed. The Medical Monitoring Project, which tracks outcomes, quality, and gaps in HIV treatment, is set to be a casualty under the Trump restructuring plan, an HIV prevention physician said. HHS officials have not communicated with the rank and file about the restructuring, several CDC workers said. 'It's been crickets,' the HIV scientist said. The White House's proposed CDC budget for the next fiscal year contains a cut of more than 50%, plummeting from $9.2 billion in fiscal year 2025 to about $4.2 billion, according to administration documents and public health advocacy groups, with some agency functions transferred to the proposed AHA. The Senate committee, by an overwhelming vote, injected billions back into the agency budget and declined to fund the AHA. U.S. Sen. Jon Ossoff, a Georgia Democrat, thanked the committee for 'rejecting the unacceptable effort to defund most of the CDC.' 'The budget request from the White House included a 56% cut to the world's preeminent epidemiological agency,' Ossoff said. He also criticized a 'systematic destruction of morale at the CDC, the disbandment of entire agencies focused on maternal health and neonatal health and disease prevention at the CDC.' If the White House prevails and the prevention program is eliminated, 'we would see most states have no funding for HIV prevention,' said Emily Schreiber, senior director of policy and legislative affairs for the National Alliance of State and Territorial AIDS Directors. 'That means most states would not be able to conduct any HIV testing, any referral to care, and/or referral to preventive services like PrEP,' or pre-exposure prophylaxis, a drug that can prevent HIV infections. 'It means that states would not be able to help people get access to medications,' she said, 'and that means that we would see new cases and an increased spread of HIV across the United States.' 'We would definitely see layoffs at the CDC, and I think we'd probably see them at state health departments and community-based organizations as well,' she added. The Los Angeles County Department of Public Health has recently laid off or reassigned dozens of HIV workers due to funding problems, according to a statement emailed to Healthbeat. 'I fear all HIV prevention work will go away permanently,' the HIV prevention researcher said. 'I don't think this administration wants HIV prevention work to be done by the federal government.' Georgia leads U.S. states in the rate of new HIV infections, according to the latest data from AIDSVu. CDC workers also said they're concerned that vulnerable communities of color and LGBTQ+ communities would be deeply harmed by funding cuts. In Georgia and other states, information provided by the Medical Monitoring Project about access to care will disappear, the HIV physician said. Information on prevention and treatment will dwindle for people who are disadvantaged, he said, including those with substance abuse problems or mental illness, transgender people, and those living in poverty. 'There is a lot of anger and sadness among people over the termination of the project,' the physician said. 'A lot of the enthusiasm is gone.' An effective home testing program for HIV plans to shutter this fall, said Patrick Sullivan, the Together TakeMeHome project's lead scientist and a professor at Emory University's Rollins School of Public Health. In its notice canceling funding for the project, the CDC said it no longer had the staff to oversee it. Based at Emory, the project delivered more than 900,000 free home testing kits to people across the country through an easy-to-use website and integration with dating apps. More than 100 HIV workers were among the more than 450 CDC staffers brought back, said employees interviewed by Healthbeat. Some cited media coverage, support in Congress, and advocacy by patient groups and pharmaceutical companies for their reinstatement. 'Members of Congress are going to bat for HIV,' the epidemiologist said. Several are closely watching a lawsuit brought by 20 Democratic attorneys general, seeking to halt an agency restructuring plan Kennedy announced in March. They are also paying attention to a lawsuit filed in California that challenges the firings. A few people whose jobs were restored have retired or moved on to other work. 'Some people aren't trusting we will remain, so they're leaving,' the HIV prevention researcher said. At the CDC's sexually transmitted infections lab in Atlanta, work has also slowed due to a shrinking staff and new spending constraints on supplies, the lab scientist said. At the CDC's sexually transmitted infections lab in Atlanta, work has also slowed due to a shrinking staff and new spending constraints on supplies, one lab scientist said. Restored lab workers are focusing on high-priority areas such as syphilis and gonorrhea while other diseases have been back-burnered, the scientist said, adding 'a lot of what we were doing was staying ahead of the next pathogen, and we feel like our time and effort to do that now is limited.' 'We're all public health because we know what the mission is,' the scientist said. 'We just want to get our job done and protect the American public.' Healthbeat is a nonprofit newsroom covering public health published by Civic News Company and KFF Health News. Sign up for its national newsletter here.
Globe and Mail
02-07-2025
- Business
- Globe and Mail
Hologic Faces Molecular Drag, But Here's Why It's Not a Major Concern
Hologic 's HOLX Molecular Diagnostics business posted a 7.8% (excluding COVID-19-related sales) growth in the second quarter of fiscal 2025, although results did not reflect its full performance was impacted by lower HIV testing sales in Africa due to significant funding cuts to USAID programs by the new administration. This $50 million annual revenue stream is now being conservatively excluded from the full fiscal outlook. Management noted that without this setback, molecular revenues would have grown at a low double-digit rate in the second quarter. Even so, the long-term trajectory of the segment remains strong. Molecular Diagnostics continues to be the principal growth driver within Hologic's Diagnostics division, with more than 20 assays running on the Panther and Panther Fusion platforms. The company is focused on driving more utilization of its existing menu, such as the test for Mycoplasma Genitalium (MGen), a prevalent but under-screened sexually transmitted disease (STD). Hologic's revenue growth strategy rests on using both lab-sales force and physician-sales force to team up with lab customers, promote screening guidelines and drive test adoption. Newer innovations, like the BV/CV/TV assay, have meaningfully contributed to growth and still offer room for more expansion. Vaginitis affects nearly 20 million women annually in the United States, yet fewer than 40% are tested. Hologic is addressing this gap by driving awareness and securing reimbursement for this high-throughput test, solidifying its position in this space. Another key asset is Biotheranostics, which Hologic acquired in 2021 to enter the fast-growing oncology adjacency. Biotheranostics' unique Breast Cancer Index test continues to see higher adoption, helping determine the benefits of extended endocrine therapy. Our model projects bullish growth for Hologic's Molecular Diagnostics arm, which is likely to expand at a compound annual growth rate (CAGR) of 7.3% during the 2025-2027 period. The Case for Hologic's Rivals Roche 's RHHBY infectious disease business was also affected by the USAID funding pause for testing, causing a decline of 5% in the first quarter of 2025. Still, without this effect, Roche's Molecular Lab grew more than 6%. The company remains optimistic about the funding pause ending and a rebound in this business. This year, Roche is set to launch the cobas BV/CV assay in CE mark countries for use on the cobas 5800/6800/8800 platforms. Abbott ABT is also exposed to the far-reaching implications of the USAID funding halt, which has disrupted the supply chain for essential medical products in underserved countries. Performance-wise, Abbott's Diagnostics business revenues dropped 5% in the first quarter of 2025 due to weak COVID-19 testing sales. The impact of volume-based procurement programs in China led to low single-digit growth in ABT's Core Laboratory Diagnostics. HOLX Stock Performance, Valuation and Estimates In the last 30 days, Hologic shares have risen 3.6% compared to the industry's 0.7% fall. Hologic is trading at a forward five-year sales multiple of 3.44X compared to the industry average of 4.11X. The stock carries a Value Score of B at present. Consensus estimates for Hologic's fiscal 2025 and 2026 earnings are showing a downward trend. Image Source: Zacks Investment Research HOLX stock currently carries a Zacks Rank #4 (Sell). You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here. Zacks' Research Chief Names "Stock Most Likely to Double" Our team of experts has just released the 5 stocks with the greatest probability of gaining +100% or more in the coming months. Of those 5, Director of Research Sheraz Mian highlights the one stock set to climb highest. This top pick is a little-known satellite-based communications firm. Space is projected to become a trillion dollar industry, and this company's customer base is growing fast. Analysts have forecasted a major revenue breakout in 2025. Of course, all our elite picks aren't winners but this one could far surpass earlier Zacks' Stocks Set to Double like Hims & Hers Health, which shot up +209%. Free: See Our Top Stock And 4 Runners Up Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Abbott Laboratories (ABT): Free Stock Analysis Report Roche Holding AG (RHHBY): Free Stock Analysis Report Hologic, Inc. (HOLX): Free Stock Analysis Report
Yahoo
12-06-2025
- Health
- Yahoo
Frederick County Health Department to offer free HIV testing
The Frederick County Health Department will offer free HIV testing as part of National HIV Testing Day this month. The free testing event will take place between 10 a.m. and 6:30 p.m. on June 27 at the Walgreens on Opossumtown Pike. The Frederick County Health Department staff will be available during the event to answer questions, provide education and connect people to additional prevention and care services such as pre-exposure prophylaxis (PReP). PReP is a medication that can reduce the risk of transmission in the event of an HIV exposure. National HIV Testing Day was first observed on June 27, 1995, according to The purpose of the day is 'to encourage people to get tested for HIV, know their status, and get linked to care and treatment.' Between 2019 and 2023, 66 people in Frederick County were diagnosed with HIV, according to data from the Maryland Department of Health's Infectious Disease Prevention and Health Services Bureau. For the majority of people diagnosed in that time frame, the HIV infection had not progressed to AIDS. Outside of the June 27 event, the Frederick County Health Department offers free walk-in testing on Tuesdays and Fridays from 9 a.m. to 3 p.m. and by appointment by calling 301-600-3117. All tests are confidential. More information about HIV services in Frederick County can be found at — Ceoli Jacoby
